Urinary alkoxyacetic acids and renal effects of exposure to ethylene glycol ethers

Occupational and Environmental Medicine

Volumn 53, Issue 9, 1996, Pages 595-600

  Laitinen, J ^a   Liesivuori, J ^a   Savolainen, H ^b  

^a FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Metabolic acidosis; Oxalic acid; Urinary stones

Indexed keywords

BUTOXYACETIC ACID; CALCIUM; CREATININE; ETHER; ETHOXYACETIC ACID; ETHYLENE GLYCOL DERIVATIVE; METHOXYACETIC ACID; OXALIC ACID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIOLOGICAL MONITORING; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; KIDNEY FUNCTION; MALE; METABOLIC ACIDOSIS; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; URINALYSIS; UROLITHIASIS;

EID: 0029741282     PISSN: 13510711     EISSN: None     Source Type: Journal    
DOI: 10.1136/oem.53.9.595     Document Type: Article

References (43)

1. Angerer J, Lichterbeck E, Begerow J, Jekel S, Lehnert G. Occupational chronic exposure to organic solvents. Int Arch Environ Health 1990;62:123-6.
2. Johanson G. Toxicokinetics of 2-butoxyethanol: uptake, distribution, metabolism and excretion in man and laboratory animals. Arbete och Hälsa 1988;3.
3. Sumner SCJ, Clarke DO, Welsch F, Fennell TR. Urinary metabolites of 2-methoxyethanol determined by NMR spectroscopy. Toxicologist 1991;11:50.
4. Carney EW. An integrated perspective on the developmental toxicity of ethylene glycol. Reprod Toxicol 1994; 2(suppl 8):99-113.
5. Cullen MR, Solomon LR, Pace PE, Buckley P, Duffy TP, McPhedran P, et al. Morphologic, biochemical and cytogenetic studies of bone marrow and circulating blood cells in painters exposed to ethylene glycol ethers. Environ Res 1992;59:250-64.
6. Larase F, Fiorito A, DeZotti R. The possible haematological effects of glycol monomethyl ether in a frame factory. Br J Ind Med 1992;49:131-3.
7. Welch LS, Schrader SM, Turner TW, Cullen MR. Effects of exposure to ethylene glycol ethers on shipyard painters: II male reproduction. Am J Ind Med 1988; 14:509-26.
8. Gray RH, Correa A. Ethylene glycol ethers and reproductive health in semiconductor workers. Abstract booklet, International Symposium on Health Hazards of Glycol Ethers. Nancy-Pont-a-Mousson, France: INRS, 1994.
9. Chiewchanwit T, Au WW. Cytogenetic effects of 2-methoxyethanol and its metabolite, methoxyacetaldehyde, in mammalian cells in vitro. Mutat Res 1994;320: 125-32.
10. Coe FL. Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria, or no metabolic disorder. Ann Intern Med 1977;87:404.
11. Baggio B, Gambaro G, Marchini F, Marzaro G, Williams HE, Borsatti A. Correction of erythrocyte abnormalities in idiopathic calcium-oxalate nephrolithiasis and reduction of urinary oxalate by oral glycosaminoglycans. Lancet 1991;338:403-5.
12. Baggio B, Gambaro G, Marchini F, Marzaro G, Williams HE, Borsatti A. Glycosaminoglycan content, oxalate self-exchange and protein phosphorylation in erythrocytes of patiens with idiopathic calcium oxalate nephrolithiasis. IRCS Journal of Medical Science 1990;79:368-9.
13. Koide T, Takemoto M, Otatani H, Takaha M, Sonoda T. Urinary macromolecular substances as natural inhibitors of calcium oxalate crystal aggregation. Invest Urol 1981; 18:382.
14. Bowyer RC, Brockis JG, McCulloch RK. Glycosaminoglycans as inhibitors of calcium oxalate crystal growth and aggregation. Clin Chim Acta 1979;95:23.
15. Nishio S, Abe Y, Wadatshui A, Iwata H, Ochi K, Takeuchi M, et al. Matrix glycosaminoglycans in urinary stones. J Urol 1985;134:503.
16. Karniski LP, Aronson P. Anion exchange pathways for Cl-transport in rabbit renal microvillus membrane. Am J Physiol 1987;253:F513-21.
17. Sasaki S, Ishibashi K, Marumo F. Transcellular chloride transport in the proximal tubules: mechanisms and physiological significance. Kidney Int 1991;33(suppl 40): 109-12.
18. Preuss HG, Slemmer D, Areas J, Conrado J. Renal ammonia production from nitrogens of glutamine in intact acidotic dogs before and after bicarbonate infusions. J Clin Chem Clin Biochem 1987;22:105-8.
19. Carlisle EJF, Donnelly SM, Vasuvattakul S, Kamel KS, Tobe S, Halberin ML. Glue-sniffing and distal renal tubular acidosis: sticking to the facts. J Am Soc Nephrol 1991;1:1019-27.
20. Liesivuori J, Savolainen H. Effects of renal formic acid excretion on urinary calcium and ammonia concentrations. Klin Wochenschr 1987;65:860-3.
21. Liesivuori J, Laitinen J, Savolainen H. Kinetics and renal effects of formic acid in occupationally exposed farmers. Arch Toxicol 1992;66:522 4.
22. Smith LH. Diet and hyperoxaluria in the syndrome of idiopathic calcium oxalate urolithiasis. Am J Kidney Dis 1991;17:370-5.
23. Robertson WG, Peacock M. The cause of idiopathic calcium stone disease: hypercalciuria or hyperoxaluria? Nephron 1980;26:105-10.
24. Sakai T, Araki T, Masuyama Y. Determination of urinary alkoxyacetic acids by a rapid and simple method for biological monitoring of workers exposed to glycol ethers and their acetates. Int Arch Occup Environ Health 1993; 64:495-8.
25. Gindler EM, King JD. Rapid colorimetric determination of calcium in biological fluids with methymol blue. Am J Clin Pathol 1972;53:376-82.
26. Ratnaike RN, Buttery JE, Hoffman S. Blood ammonia measurement using a simple refractometer. J Clin Chem Biochem 1984;22:105-8.
27. Savolainen H. Sensitive method for analysis of urinary proteoglycans. Biochem Int 1992;28:475-9.
28. American Conference of Govermental Industrial Hygienists (ACGIH). Threshold limit values for chemical substances and physical agents and biological exposure indices. Cincinnati, OH: ACGIH, 1994-5.
29. Deutsche Forschungsgemeinschaft (DFG) MAK- und BAT-Werte-Liste 1994. Senatskomission zur Prüfung geseundheitsschädlicher Arbeitsstoffe, 30 Aufl. Weinheim: BRD:VCH Verlagsgesellschaft mbH, 1994.
30. Kohri K, Kodama M, Ishikawa Y, Katayama Y, Kataoka K, Iguchi M. Simple tests to determine urinary risk factors and calcium oxalate crystallization in the outpatient clinic. J Urol 1991;146:108 12.
31. Groesneken D, Veulemans H, Masschelein R, van Vlem E. Comparative urinary excretion of ethoxyacetic acid in man and rat after single low doses of ethylene glycol monoethyl ether. Toxicol Lett 1988;41:57-68.
32. Groesneken D, Veulemans H, Masschelein R, van Vlem E. Experimental human exposure to ethylene glycol monomethyl ether. Int Arch Occup Environ Health 1989; 61:243-7.
33. Veulemans H, Groesneken D, Masschelein R, van Vlem E. Survey of ethylene glycol ether exposures in Belgian industries and workshops. Am Ind Hyg Assoc J 1987; 48:671-6.
34. Jacobsen D, Hewlett TP, Webb R. Ethylene glycol intoxication: evaluation of kinetics and crystalluria. Am J Med 1988;1(suppl 84):145-52.
35. Suleimani M, Bizal GL, Anderson CC. A protein with anioin exchange properties found in the kidney proximal tubule. Kidney Int 1993;44:565-73.
36. Moore DF, Bentley AM, Dawling S, Hoare AM, Henry JA. Folinic acid and enhanced renal elimination in formic acid intoxication Clin Toxicol 1994;32:199 204.
37. Laitinen J, Liesivuori J, Savolainen H. Exposure to glycols and their renal effects in motor servicing workers. Occup Med 1995;4S:259-62.
38. Shum DKY, Gohel MDI. Separate effects of urinary chondoitrin sulphate and heparan sulphate on crystallization of urinary calcium oxalate: differences between stone former and normal control subjects. Clin Sci 1993;85: 33-9.
39. Williams HE, Wandzilak TR. Oxalate synthesis, transport and hyperoxaluric syndromes. J Urol 1989;141:742-7.
40. Holmes RP, Goodman LJ, Hart LJ, Assimos DG. Relationship of protein intake oxalate and glycolate excretion. Kidney Int 1993;44:366-72.
41. Hayashi Y, Kaplan RA, Pak CYC. Effect of sodium cellulose phosphate therapy on crystallization of calcium oxalate in urine. Metabolism 1975;24:1273.
42. Laerum E, Aarseth S. Urolithiasis in railroad shopmen in relation to oxalic acid exposure at work. Scand J Work Environ Health 1985;11:97 100.
43. Laerum E. Recurrent urilithiasis in general practice: an epidemiological study from a Norwegian district. Scand J Urol Nephrol 1984;18:67-70.